Clinical trial
Study of Tauroursodeoxycholic Acid for Hepatobiliary Disease in Cystic Fibrosis
NCT00004441 · Children's Hospital Medical Center, Cincinnati, Other · Completed
Key facts
| NCT number | NCT00004441 |
|---|---|
| Title | Study of Tauroursodeoxycholic Acid for Hepatobiliary Disease in Cystic Fibrosis |
| Lead sponsor | Children's Hospital Medical Center, Cincinnati, Other |
| Status | Completed |
| Study type | Interventional |
| Conditions | Cystic Fibrosis |
| Intervention type | Drug |
| Interventions | tauroursodeoxycholic acid, ursodiol |
| Enrollment | 39 |
| Start date | Sep 1, 1997 |
| Completion | Sep 1, 2001 |
| First posted | Oct 19, 1999 |
| Last update posted | Mar 25, 2015 |
| Countries | Italy, United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: